Document Detail


Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
MedLine Citation:
PMID:  18417124     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Osteoprotegerin (OPG) and the receptor activator of nuclear factor-kappaB ligand (RANKL) are inflammatory cytokines traditionally linked to the regulation of bone remodeling. We hypothesize that the OPG/RANK/RANKL axis may be involved in extracellular matrix remodeling in immuno-inflammatory heart diseases, and explore the probable underlying mechanisms by using anti-IL-17 in the model of experimental autoimmune myocarditis. METHODS: EAM was induced in Lewis rats by injection of porcine cardiac myosin. All the rats were randomly distributed into day 0, day 7, day 14 and day 28 groups, which means rats in certain group were cervical dislocated on day 0, day 7, day 14 and day 28 respectively. HE staining and Masson's staining were used for measurement of cardiac hypertrophy and interstitial fibrosis. Hydroxyproline content and collagen cross-linking were determined in heart section. Anti-IL-17 or control antibody was injected i.p. 2 h before and 3 days and 7 days after the first myosin immunization in EAM model, that is, group anti-IL-17 or group control antibody. IL-17 and OPG/RANK/RANKL axis expressions were detected by realtime RT-PCR in all the six groups. In the in vitro studies, cardiac fibroblasts were cultured and treated with IL-17 or vehicle for 48 h. Total RNA was isolated from harvested cells and realtime RT-PCR was performed to detect the RANK, RANKL, OPG and MMP-2, MMP-9, TIMP-1 and TIMP-2 expressions, then matrix metalloproteinase activity was assayed. RESULTS: Our in vivo results revealed that expression of IL-17 and the OPG/RANK/RANKL axis increased significantly from day 0 to day 28, with IL-17 and OPG increased relatively steeply. In the in vitro study, we detected OPG, RANK and RANKL mRNA expressions in the cultured fibroblasts with or without IL-17 stimulation. We found that IL-17 increased the OPG/RANK/RANKL axis activity (P<0.05). Although IL-17 induced a significant increase in MMP-2 and MMP-9 gene expressions in cardiac fibroblasts, there was no change in TIMP-2 and TIMP-1 expressions. CONCLUSIONS: Our results suggest that the OPG/RANK/RANKL axis may be involved in cardiac remodeling in immuno-inflammatory myocardial diseases and progression of chronic HF and thus may represent targets for intervention in this disorder.
Authors:
Wei Liu; Weiwei Feng; Fang Wang; Weimin Li; Cheng Gao; Baoguo Zhou; Manling Ma
Related Documents :
11064274 - Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polya...
17211254 - Therapeutic effects of angiotensin ii type 1 receptor blocker at an advanced stage of h...
3764934 - Effects of prenatal nitrofen exposure on cardiac structure and function in the rat.
7903664 - Growth, nitrogen metabolism, and cardiac responses to clenbuterol and ketoclenbuterol i...
24348784 - Protective effect of panax quinquefolium 20(s)-protopanaxadiol saponins, isolated from ...
9350654 - Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of inte...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-03-07
Journal Detail:
Title:  Experimental and molecular pathology     Volume:  84     ISSN:  1096-0945     ISO Abbreviation:  Exp. Mol. Pathol.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-07-07     Completed Date:  2008-09-18     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0370711     Medline TA:  Exp Mol Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  213-7     Citation Subset:  IM    
Affiliation:
Department of Cardiology, First Affiliated Hospital, Harbin Medical University, Heilongjiang, 150001, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Autoimmune Diseases / immunology,  metabolism,  pathology
Cells, Cultured
Extracellular Matrix / metabolism
Fibroblasts / metabolism
Fibrosis
Interleukin-17 / immunology
Male
Matrix Metalloproteinase 2 / metabolism
Matrix Metalloproteinase 9 / metabolism
Myocarditis / immunology,  metabolism,  pathology*
Myocardium / pathology
Myosins / immunology
Osteoprotegerin / physiology*
RANK Ligand / physiology*
Rats
Rats, Inbred Lew
Rats, Wistar
Receptor Activator of Nuclear Factor-kappa B / physiology*
Swine
Tissue Inhibitor of Metalloproteinase-1 / metabolism
Tissue Inhibitor of Metalloproteinase-2 / metabolism
Ventricular Remodeling*
Chemical
Reg. No./Substance:
0/Interleukin-17; 0/Osteoprotegerin; 0/RANK Ligand; 0/Receptor Activator of Nuclear Factor-kappa B; 0/Tissue Inhibitor of Metalloproteinase-1; 127497-59-0/Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9; EC 3.6.4.1/Myosins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human in vivo research on the vascular effects of adenosine.
Next Document:  Enhanced function in the good forelimb of hemi-parkinson rats: compensatory adaptation for contralat...